key: cord-0748923-p92uw5c9
authors: Houchi, Selma; Messasma, Zakia
title: Exploring the inhibitory potential of Saussurea costus and Saussurea involucrata phytoconstituents against the Spike glycoprotein receptor binding domain of SARS-CoV-2 Delta (B.1.617.2) variant and the main protease (M(pro)) as therapeutic candidates, using Molecular docking, DFT, and ADME/Tox studies
date: 2022-04-09
journal: J Mol Struct
DOI: 10.1016/j.molstruc.2022.133032
sha: 1f6c2cdada6b3228f9c5506aeb9cc128b57351be
doc_id: 748923
cord_uid: p92uw5c9

The B.1.617.2 Delta variant is considered to be the most infectious of all SARS-CoV2 variants. Here, an attempt has been made through in-silico screening of 55 bioactive compounds from two selected plants, Saussurea costus and Saussurea involucrata as potential inhibitors of two viral proteases, main protease Mpro (PDB ID:6LU7) and the RBD of SGP of Sars-CoV-2 B.1.617.2 Delta variant (PDB ID:7ORB) where the binding energy, molecular interactions, ADMET/Tox, chemical descriptors and Quantum-Chemical Calculations were explored. Molecular docking results demonstrated that the three top docked compounds formed relatively stable complexes within the active site and displayed remarkable binding energy in the order of Tangshenoside III, Rutin and Hesperidin (-9.35, -9.14 and -8.57 kcal/mol, respectively) with Mpro and Rutin, Tangshenoside III and Hesperidin (-9.07, -7.71 and -7.57 kcal/mol) with RBD of SGP. These compounds are non-Mutagen and non-carcinogen. Therefore, according to the Lipinski's Rule of Five they exhibited three violations concerning hydrogen acceptor, donor and molecular weight. However, based on the Quantum-Chemical Calculations results the selected ligands have effective reactivity, as they showed lower band gaps. The difference of the E(LUMO) and E(HOMO) was low, ranging from 0.0639 to 0.0978 a.u, implying the strong affinity of these inhibitors towards the target proteins. Among the three inhibitors, Rutin exhibited higher reactivity against two viral proteases, main protease (Mpro) and the Sars-CoV-2 B.1.617.2, as the band energy gap was lowest among all the three phytochemicals, 0.0639 a.u This could indicate that Rutincan be potential anti-viral drug candidates against the existing SARS-CoV-2, the B.1.617.2 Delta variant.

II could be an attractive target domain for the treatment of the development of new antiviral drugs anti-B.1.617.2 infection and prevention of the risk of multi-organ failure.

It is well known that, over the past decades, medicinal plants have been attracting attention in the search for bioactive compounds to develop new drugs and healthy foods among which polyphenols, lipids, polysaccahrides, sterols, terpenes. Furthermore, various plant extracts were reported to have high antioxidant, anti-cancer activity and to influence anti-inflammatory responses. However, plant based medicines are widely used due to their wide acceptance and therapeutic effects with minimal side effects [11, 12] . Hence, at such a time, herbal medicine have shown experimentally promising results in SARS CoV-2 inhibition. Recently, various studies have highlighted the implication of a variety of phytoconstituents which has the potential to be developed as antiviral agents for SARS-CoV-2 [13, 14, 15] .

The genus Saussurea DC. of the flowering plant family Asteraceae comprises about 300 species in the world. A family that is rich with well-known medicinal plants of highly economic importance. Many of which have been intensively studied for their phytochemical constituents and medicinal applications, including S. lappa. [16] and S. involucrata. [17] .

Traditional clinical applications were considered guide for bioactivity evaluations, and many correlations were found between the pharmacological actions in traditional records of the herb and bioactivities confirmed in modern studies [18] . S. lappa. and S. involucrata are traditionally used to treat a wide spectrum of disorders; its pharmacological evidence is grounded by long history of usage and promising experimental results.

Saussurea costus (Falc.) Lipschitz, a perennial herbaceous plant, one of the bestknown species within this genus, is commonly known as costus in English. It has several synonyms, such as Aucklandia costus Falc., Aplotaxis lappa Decne., Saussurea costus (Falc, )

Sch.-Bip., Aucklandia lappa Decne, Saussurea lappa (Decne.) C. B. Clarke., Theodorea costus O. Kuntz [19] . Several workers have reported on the different biological activities of Saussurea costus in various in vitro and in vivo test models. Pharmaceutical effects investigations of extracts from Saussurea costus roots have been found to exhibit antiinflammatory [20] , hepatoprotective [21] , anti-ulcer [22] , anticancer [23] , would-healing [24] , antifungal and antimicrobial [25] , anticonvulsant [26] , larvicidal [27] and protein tyrosine phosphatase 1B inhibitory [28] activities.

Another Saussurea species, S. involucrata Karel. & Kir. with large translucent creamcolored bracts concealing the huge inflorescence, are named 'glasshouse plant' [29] .

According to "The Plant List", S. involucrata Matsum. & Koidz is the only accepted name for the herb, with asynonym "S. involucrata (Kar. & Kir.) Sch. Bip." [30] .

More recent studies have shown that this plant have anti-inflammatory, analgesic [31] .

Immunomodulatory [32] , antioxidative [33] , antihypoxic and neuroprotective [34] , cardiovascular diseases [35] , allergies and asthma [36] .

The research and the development of a drug molecule "drug discovery" is often an extremely long, tedious and very expensive process at high risk of failure. For each new drug, the time elapsing between the first step, during which a relevant biological target in a given disease process is identified, until a drug is placed on the market is estimated at an average of 12 to 14 years [37] . An alternative approach, such as virtual screening or rational drug design, are now routinely used to guide drug discovery. The use of these in silico techniques could improve the efficiency and save the cost of drug discovery [38] .Virtual screening approaches based on the structure of the target, more specifically the molecular docking, predict possible modes of interaction between a ligand and the therapeutic target and provide a way of studying interactions at the molecular level and are, therefore, an indication of the biological activity of new molecules taking into account only structural criteria.

In this context, we conducted computational screening study on a library of 55 isolated molecules from Saussurea costus and Saussurea involucrata, investigated the ADMET/tox studies, the DFT calculations and the binding affinity, of these compounds with the key target RBD of SGP SARS-CoV-2 B.1.617.2 and the main protease (M pro ) through molecular docking analysis.

Molecular docking and ADMET/Tox studies were performed using Molecular Operating Environment (MOE) version 2019.10 molecular modelling software and Discovery Studio (DS) 2.0 Software (Studio 2.5, Accelrys, Co. Ltd., San Diego, CA, USA), respectively. DFT calculations were performed by Gaussian 09 suite of program at 6-31G (d,p) basis set.

A total of 55 compounds were included in the screening (Table 1) , encoded by S. lappa. and S. involucrate medicinal plants, after a profound literature review. Structure Data Format of these bioactive phytoconstituents were retrieved from the PubChem database (www.pubchem.ncbi.nlm.nih.gov) alongside the reference inhibitors (N3 and Hydroxychloroquine for M pro and Spike glycoprotein, respectively).

As molecular targets, three important proteins for SARS-CoV2 infection were obtained from protein data bank of the Research Collaboration for Structural Bioinformatics (RCSB), website (http://www.rcsb.org/pdb) in PDB formats. This including the Main Protease (Mpro) (also called 3C-like protease _ 3CLpro), which represents a pivotal role in the propagation of SARS-CoV-2. The crystal structure of this enzyme was downloaded in complex with its inhibitor N3, (PDB ID: 6LU7; 2.16 A°). The crystalline structure of the L452R mutant receptor binding domain (RBD) of SARS-CoV-2 Spike glycoprotein (SGP) was downloaded in complex with COVOX-75 and COVOX-253 Fabs (PDB code: 7ORB; 2.5 A°). However, the crystalline structure of the Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2) was downloaded without inhibitor (PDB ID:

1R42; 2.20 A°).

The three targets proteins, 6LU7, 7ORB and 1R42 used in this study, was protonated where hydrogen atoms were added with their 3D geometry, corrected for any found errors in the connection or type of different atoms, and then energy minimized at the end of the preparation steps. This step followed by site-finder to define and isolate the same binding pocket of the co-crystallized native inhibitor as dummy atoms over helix for the docking step.

Structures of the phytoconstituents of Saussurea genus were surveyed and downloaded from the PubChem database in structure data format (SDF). Then, Energy minimizing of these ligands was done under the following conditions: temperature = 300 K, pH = 7.

Furthermore, the geometry was performed using the field strengths in the MMFF94x implanted in MOE and Austin model 1 (AM 1) with gradient value of 0.0001 kcal/mol. Then, the compounds were saved in mdb format as a new database.

The dock tool of Molecular Operating Environment (MOE) 2019.0102 software was used for fitting of the isolated compounds' database into the active site of SARS-CoV-2 and ACE-2 enzymes. Docking site was selected as dummy atoms, alpha triangle as the placement methodology, and London dG as the scoring methodology. The docking process was run followed by evaluation of poses. Poses with the highest energy scores and best ligand-enzyme interactions were selected and recorded.

Lipinski's Rule of Five [39] was used to investigate phytoconstituents that were selected for this study. Filters like Molecular weight of the ligand (<500 Da), high lipophilicity (LogP<5), number of hydrogen bonds donors (<5), number of hydrogen bond acceptors (<10) and lip druglike were used to carry out the further selection of this compounds.

Violation of more than 2 of the above-stated parameters debarred further analysis of a particular molecule. Parameter details were calculated using Molecular Operating Environment (MOE) 2019.0102 software.

A computational study of the top ten docking inhibitor compounds of each protein was carried out for the prediction of pharmacokinetics ADMET (Absorption, Distribution, Metabolism, Excretion and Hepatotoxicity) properties. In this module, eight mathematical models, such as solubility and its level, HIA (human intestinal absorption), ADMET AlogP98, ADMET PSA-2D, BBB penetration level PPB (plasma protein binding), ADMET CYP2D6 and hepatotoxicity were predicted via Discovery Studio (DS) 2.0 Software (Studio 2.5, Accelrys, Co. Ltd., San Diego, CA, USA)

Another method used to determine the therapeutic compatibility of the drug is toxicity prediction by using the USFDA (US FDA, United States Food and Drug Administration) standard toxicity risk predictor software TOPKAT in the Discovery Studio. Toxicity by TOPKAT and prediction, TOPKAT rat female NTP probability and prediction TOPKAT rat male NTP probability and prediction, developmental toxicity potential, aerobic biodegradability, ocular irritancy, skin irritancy and Daphnia EC 50 .

All Density Functional Theory (DFT) calculations were performed by using the Gaussian 09 program package [40] and the output files were visualized by means of Gauss View 5.0.8 program [41] . Quantum chemical calculations such as optimized geometries and corresponding molecule orbitals (MOs) energies, Mulliken atomic charge and molecular electrostatic potential (MEP) were obtained at B3LYP (Becke's three parameter hybrid model using the Lee-Yang Parr correlation functional) [42, 43] level of density functional theory (DFT) with 6-31G(d,p) basis set [44] .

The tested library of active constituents from S. lappa. and S. involucrata comprised phytochemicals that cover major classes of natural products. Phytochemical studies of the two Saussurea plants showed the presence of terpenes (sesquiterpenes and steroids); polyphenols (flavonoids and lignans); aromatic acids (phenolic and hydroxycinnamic acids) and others.

Closely-related plants species often share similar secondary metabolites and bioactivities.

The two Saussurea species shows resemblance in bioactivities as well as phytochemical constituents (References against each phytochemical constituents candidate plants have been shown in Table 1 ).

Saussurea is a medicinal plant of immense medicinal importance having a variety of compounds and diversity in the pharmacological spectrum. It is used to treat fever, headache, cough, bronchial asthma [59] , diarrhea [60] , cholera [61] , tuberculosis, vomiting, dyspepsia [59, 60] , gastric ulcer [60] , abdominal pain [59, 60] . Different studies reported that Saussuria active compounds have antiviral activity including SARS-CoV-2. Prawiro et al. searched to make evidence-based medicine that Honey, Saussuria coctus and Nigella may cure the Covid-19. They divided mice into two groups, the first group as control received PBS as a placebo.

Then the second group, received Honey, Saussuria coctus and Nigella sativa. After administration regiments a long three weeks, they sacrificed the mice and evaluated the immune responses markers that are Th2, Th17 for cellular, and NK cells , TGF-β, IL-17A, sIgA, IL-4, IL4, B-def, and IgG for humoral. As results, they reported a statistically deference in the cellular immune responses markers, Th2 and Th17, between control with treatment group (p=0.05) and a deference in the markers of humoral immunity (p=>0.05). However, the markers of humoral immunity (IL-17A) have no statistical difference [62] . Another study evaluated the crude extract prepared from Saussuria coctus for its antiviral activity against Hepatitis B Virus (HBV). Two compounds Costunolide and Dehdrocostuslactone suppressed the expression of Hepatitis B surface antigen (HBsAg) in a dose dependent manner with an IC 50 value of 1.0 and 2.0 mM in Human hepatoma Hep3B cells. Significant suppression was also observed in human hepatoma cell line HepA2 derived from the HepG2 cells [63] . These findings suggest that Saussuria coctus may have the potential to develop as specific anti-virus drugs such as anti-SARS-CoV 2.

« Table. 1»

Plants are sources of phytoconstituents which has the potential to be developed as antiviral agents for SARS-CoV-2, as has been reported by previous studies [13, 14, 15, 64] . Since ligand binding to a protein of interest is the first step in drug discovery, molecular docking is widely used to predict and identify ligands that fit into the binding pocket of a protein of interest [65] . Molecular docking is not only cost effective but also time effective approach to identify a promising therapeutics agent of COVID-19.

Several methods are used to evaluate the performance of the different programs of docking for each application. The ability of an algorithm to find the correct location of the ligand in relation to its receptor is usually determined by means of the deviation root meansquare-deviation (RMSD) of the model designed by the software against the crystal structure.

The RMSD test was performed on complexes formed between the SARS-CoV-2 receptors and different ligands. The obtained molecular docking results were considered valid since redocking the orginal ligands (N3). The accepted value is a maximum difference of 2 angstroms beyond which the prediction is considered as inadequate [66] . The obtained molecular docking results were considered valid since redocking the crystalized ligands (N3 and Hydroxychloroquine) furnished great ligand superposition with root-mean standard deviation (RMSD) below 2 Å. Scores, RMSD_refine values, and diverse interactions of the best top scoring ligands with the amino acids of the Mpro, RBD of SGP and ACE-2 pockets are described in Table 2 .

The molecular docking has been performed using the Molecular Operating Environment 

According to the 3D structure of SARS-CoV-2 Mpro, the active Mpro homodimer comprises two protomers, constituting three domains. Amino acid residues 8-101 constitute Domain I, amino acid residues 102-184 constitute Domain II, and amino acid residues 201-306 constitute Domain III. Before analyzing ligand-receptor interactions, we have defined binding site residues of Mpro enzyme. Binding site of Mpro enzyme contains Thr24, Thr25, Thr26, Leu27, His41, Met49, Tyr54, Phe140, Leu141, Asn142, Gly143, Ser144, Cys145, His163, His164, Met165, Glu166, Leu167, Pro168, His172, Asp187, Arg188, Gln189, Thr190, Ala191, and Gln192 residues. The S1 binding site is formed by Phe-140, Asn-142, Ser-144, with the backbone of Thr-26 define S1' site. His41 and Cys145 form the catalytic dyad in the active site [67] and His164 is essential for enzyme activity. His163, His172 and Glu166 are believed to provide the opening gate for the substrate in the active state of the protomer [68] , and Thr24, Thr26 and Asn119 are predicted to play roles in drug interactions [69, 70] .

The formation of hydrogen bonds defines the integrity and stable nature of each protein-ligand complex. Table. 2 Figure. 1 and 2. Ghosh et al., [71] reported that polyphenols like broussochalcone A, papyriflavonol A, 3′-(3-methylbut-2-enyl)-3′,4′,7-trihydroxyflavane, broussoflavan A, kazinol F, and kazinol J had good interaction with the catalytic residues of His41 and Cys145 of Mpro. These amino acids interactions with the SARS-CoV-2 main protease Mpro are similar to our findings. Previous studies reported that the inhibitor N3 docks in the active binding site of 6LU7 and forms hydrogen bonds with PHE 140, GLY 143, THR190, HIS 164, GLU166 and GLN189 [72] and these results similar to our finding. A recent study performed by Cherrak SA et al (2020) showed that Rutin possesses high docking scores of -9.2 kcal/mol and interacts with Mpro via conventional H-bonds at Thr26, Tyr54, Leu141, and Glu166, π-cation interactions at His41, π-alkyl interactions at Met49, π-sulfur interactions at Cys145, and C-H bond interactions at Met165. These results indicate that rutin [73] . Another investigation reported that Rutin was found to have, with Mpro, a docking score of -9.16 kcal/mol, it was considered to be a potential Mpro inhibitor. Rutin was predicted to form hydrogen bonds involving Cys145, Asn142, Gly143, and Thr190, with additionally the possible formation of σ-π stacking interaction with Gln189. Notably, the major binding affinity was based on the presence of a hydroxyl group, which presented the key to anchoring and blocking the substrate into the active pocket of the catalytic center [74] .

Hesperidin inhibit the cleavage activity of the Mpro in a dose-dependent manner in cell-free and cell-based assays, with an IC 50 of 8.3 μM [75] . A previous study also showed that the docked hesperidin compound against Mpro was -13.51 [76] , and according to a previous investigation, the best hesperidin position against SARS-CoV-2 Mpro had a score of -10.1 [77] [78] . Furthermore, Rameshkumar et al, (2021) docked 36 flavonoid to the active site of Mpro and it was observed that the compound agathisflavone had shown the highest binding energy value of -8.4 kcal/mol and interacts with Mpro by t hydrogen bonds at Lys102, Thr111, Ser158, His246 followed by Dracorubin and Cupressuflavone that showed dock score of -8.2 kcal/mol [79] . As presented in a previous study reported that several potentially active compounds have best docking scores which are cannabinoids, rhoifolin, pectolinarin, morin, kaempferol, epigallocatechin gallate, herbacetin, and hesperidin against 3CLpro were -8, - (Table. 2). The detail of interaction and visualization of the docking results of these complexes with ACE-2 is provided in Figure. 

Drug-like properties and pharmacokinetic properties are intrinsic characteristics of drugs that may need to be optimized independently from pharmacodynamics properties during drug development. It is a balance among molecular properties affecting pharmacodynamics and pharmacokinetics of small molecules.

The drug-likeliness of top ten drug ligands for both SARS-CoV-2 Mpro and spike proteins was evaluated through Lipinski's rule of five parameters and the values are summarised in Table 3 (values of all the molecules are mentioned in supplementary Data (Table S1 ). This rule is based on physicochemical parameters of the tested ligands, including: Molecular weight (MW) not greater than 500 g/mol; A partition coefficient log P less than or equal five; number of hydrogen bond donors (HBD) (NH and OH groups) not greater than five; and number of hydrogen bond acceptors (HBA) (O and N atoms) not exceeds ten. Drugs having log P ranging from 0 to 5, have high possibility of oral absorption.

Not more than one violation of these parameters will reduce the druggability of the molecule [105] .

All the screened compounds were found to have little violation and it was believed to effective despite of few violations, except edultin that was fully in agreement to Lipinski's rule of five (without violation). β-sitosterol and Epicatechin gallate also qualified Lipinski's rule of five with one violation concerning Log P and hydrogen donor, respectively. Except for β-sitosterol Daucosterol all other drug molecules showed the value of Log P less than 3.53, which indicates that the molecules are more likely to be in the hydrophilic environment and are favorable for their drug-likeness. Daucosterol has another violation regarding the molecular weight. His molecular weights is slightly more than the recommended values but within the permissible limit. Quercitrin, Luteolin-7-glucoside and Quercetin-3-glucoside exhibited two violation regarding hydrogen acceptor and donor as well as Arctiin showed two violations regarding hydrogen acceptor and molecular weight. Tangshenoside III, Rutin and Hesperidin exhibited three violations concerning hydrogen acceptor, donor and molecular weight.

The determination of pharmacokinetic properties of drugs at the preliminary stages of drug discovery is essential to bring the drug up to clinical trial [106] . These properties such as absorption, distribution, metabolism, excretion and hepatotoxicity (ADMET) are important in order to determine the role in drug discovery and success of the development of compound for human therapeutic use. To determine the drug-likeliness of our compounds, we calculated their ADMET properties. ADMET prediction was done using Discovery Studio 2.5 (Accelrys, San Diego, USA) software. Prediction is based on two 2D molecular descriptors, namely AlogP_98 and PSA. As shown in Figure 7 , Compounds with more than 90 % absorbability would lie within the 99 % confidence ellipse as the green ellipse Compounds falling out of the ellipse are those with less than 30 % absorbability. The results of ADMET were displayed in Table 4 , revealing eight descriptors, such as the absorption of drugs depends on intestinal absorption, polar surface area (PSA) and AlogP98. The distribution depends on factors that include the blood-brain barrier (BBB) and plasma protein binding (PPB). Metabolism is predicted based on the Cytochrome P450 2D6 inhibition and hepatotoxicity. ADMET aqueous solubility predicts the solubility of each compound in water at 25∘C. ADMET solubility descriptors predicts molar solubility of drugs within the ranges: < -8.0 (level 0 = extremely low solubility), -8.0 to -6.0 (level 1 = very low, but possible) -6.0 to -4.0 (level 2 = low), -4.0 to -2.0 (level 3 = good solubility), and -2.0 to 0.0 (level 4 = optimal solubilty).

Except β-sitosterol and Rutin ADMET Aqueous solubility logarithmic level of most of the compounds was found to be 2, 3 which indicates low or good aqueous solubility, respectively.

ADMET absorption predicts human intestinal absorption (HIA) after oral administration.

Intestinal absorption of drug was determined by obtained levels: 0 (good), 1 (moderate), 2 (low), 3 (very low). Daucosterol and Edultin were found to have moderate to good HIA whereas, all other ligands were found to have very low absorption level, therefore are poor in gastro intestinal absorption. High hydrogen-bonding capacity of molecules has ebeen reported as one of the most important factors affecting intestinal absorption of new chemical entities.

As the generally respected ''rule of 5'' suggests, any molecule having more than 5 hydrogen bond donors and 10 hydrogen bond acceptors would normally face poor absorption consequences. Easy distribution of the drug through blood brain barrier (BBB) measured by its AlogP98 value which must be less than 5. The obtained absorption levels determine drug absorption and absorption decreases inversely with the level, i.e., level 0 denotes proper absorption, level 1 denotes moderate absorption and so on. All the compounds were fallen outside the 99% ellipse (undefined). Hence, the compounds may not be able to penetrate the blood brain barrier. ADMET plasma protein binding model predicts whether a compound is likely to be highly bound to carrier proteins in the blood. Predictions are based on AlogP98 and 1D similarities to two sets of "marker" molecules. True symbolizes binding and false symbolizes non-binding. The ADMET plasma protein binding property prediction clearly suggesting that all of 12 compounds with an exception of β-sitosterol and Epicatechin gallate , are not likely to be highly bound to carrier proteins in the blood. ADMET CYP2D6 binding predicts cytochrome P450 2D6 enzyme inhibition using 2D chemical structure as input as Lipinski's rule, including molecular weights, hydrogen bond acceptors and donors. Thus, these compounds are predicted to be hardly transported, diffused, and absorbed than compared with the small molecules. On the other hand, the most popular and authentic rule for confirming the drug-likeness of the Ligand is Lipinski's rule. However, many drugs that do not pass through the Lipinski's filter but have immense pharmacological properties have been approved by the FDA as potential drug for clinical purposes [107] . Despite violation of some rules, approved anticancer and anti-infective drugs from natural products or their semisynthetic derivatives such as taxol and amphotericin B have also some violations but are biologically effective as drugs. Therefore, these results do not interfere with the development of these compounds as potential SARS-CoV-2 therapeutic agents [108] .

« Table. 4» « Figure. 7» 

The toxicity predictions of the compounds were also investigated with Discovery Studio using the TOPKAT protocol. TOPKAT is a computational tool for in-silico quantitatively Table 5 . Our results indicate that all ligands are non-Mutagen, non-carcinogen with Rat female NTP. Therefore, the toxicity of the ligands was found to be suitable for the development into a medical drug. Thus, they experience significant first-pass effect.

After sorting the common top three drug ligands (Tangshenoside, Rutin and Hesperidin) based on their highest negative binding energies value. These drug ligands are quite similar with different binding energies towards the three targets. The above-mentioned drug ligands were subjected to Quantum-Chemical Calculations studies.

Optimized geometries of the investigated compounds obtained from DFT calculations using B3LYP/6-31G(d,p) method are given in Figure. 8. The absence of imaginary frequencies confirmed the global minima on the potential energy surface. Calculated geometric parameters of the investigated compounds are given in Supplementary Data (Table S2 ). « Figure. 8» 

The distributions and energy levels of the HOMO and LUMO orbitals, computed with the B3LYP/6-31G(d,p) level for Tangshenoside III, Rutin and Hesperidin are shown in Figure 2 .

To understand the relationship between electron delocalisation and reactivity of studied compounds, density plots of the HOMO and LUMO composition of studied compounds can be used ( Figure 9 ). As shown in Figure 9 , the positive region is presented in red and the negative one in green to further determine the relationship between delocalisation and reactivity, global descriptors were applied. Important factors used to describe inhibition activity of selected phytochemicals plant against two viral proteases, main protease (Mpro) and

the Sars-CoV-2 B.1.617.2 and ACE-2 are HOMO and LUMO energies and HOMO-LUMO energy gaps (Egap) [110] . The structure with the lower LUMO energy is a weak electron acceptor while the structure with the higher HOMO energy is a good electron donor [111] .

The HOMO and LUMO energy values as well as Egap values of the studied compounds are shown in Table 6 . 

The optimized geometries obtained with B3LYP/6-31G (d,p), were used for global chemical reactivity calculations. The reactivity parameters were calculated according to the approximations of energies E HOMO and E LUMO states, based on the optimization of the fundamental state geometry. The calculated parameters were: Energy Gap (Egap), ionization potential (I), electronic affinity (EA), chemical potential (μ), electronegativity (χ), and chemical hardness (η). The obtained results are shown in Table 6 , in which is observed that Rutin presents a higher capacity to form anions due to the electronegativity value (χ), which represents a greater tendency to attract electrons. Regarding chemical hardness (η), Rutin shows a lower value compared to Tangshenoside III and Hesperidin; this parameteris indicative of the good interaction of this molecule with the surrounding environment. As the energy gap increases, the molecule becomes harder and more stable/less reactive [112, 113] .

Tangshenoside III and Hesperidin. The values of electronic chemical potential of Tangshenoside III, Rutin and Hesperidin are presented in Table 6 , ligands that have the greater electronic chemical potential (absolute values), was the less stable and more reactive.

These results showed that the selected phytochemicals have effective reactivity, as they showed lower band gaps. The difference of the E LUMO and E HOMO was low, ranging from 0.0639 to 0.0978 a.u, implying the strong affinity of these inhibitors towards the target proteins. Among the three phytochemicals, Rutin exhibited higher reactivity against two viral proteases, main protease (Mpro) and the Sars-CoV-2 B.1.617.2, and ACE-2 as the band energy gap was lowest among all the three phytochemicals, 0.0639 a.u (Table 6 ).

The molecular electrostatic potential (MEP) can predict the reactive sites of electrophilic and nucleophilic attack in a molecule. These MEPs were realized to show the electron density within the Tangshenoside III, Rutin and Hesperidin on surfaces that surround the molecules, and the locations of sites for nucleophilic and electrophilic attacks [114, 115] . 

The Mulliken atomic charges of Tangshenoside III, Rutin and Hesperidin were calculated by DFT using B3LYP/ 6-31G (d,p) basis set, the data were tabulated in Table S3 . It showed that the C5 is the most positive charge and O26 have the most negative charge for Tangshenoside III. On the other hand, it is observed that the most nucleophilic center of Rutin is O29 which is the most electrophilic susceptibility positions, it is obvious that the nucleophilic susceptibility of the Rutin is recognized on C21 and C27 sites. However, O42 is the most negative charge of Hesperidin and their respective positively charged atom is C22. The positively charged centers are the most susceptible sites for nucleophilic attacks, electron donation. However, the most negatively charged centers are the most susceptible sites for electrophilic one. The graphical representation for Mulliken atomic charges of the Tangshenoside III, Rutin and Hesperidin is shown in Figure 11 . As it can be observed from this figure, the calculated atomic charges for the more negative atoms are the oxygen atoms while, the opposite case represented by the attached protons, are the most positive atoms.

Again, this charge distribution supports the idea that the molecule donates its electrons through these groups. « Figure. 11»

To the best of our knowledge, Tangshenoside III was not tested for SARS-CoV-2 inhibition or any other enzyme activity. However, previous studies provide a strong rationale for testing rutin and hesperidin in SARS-CoV-2.

Various pharmaceutical properties associated with rutin are anti-inflammatory [116] , antitumor [117] , antiulcer [118] , antimalarial [119] , antimicrobial [120] , anticoagulant [121] , nephroprotective [122] , hepatoprotective [123] .

Rutin was also found to decrease the infectivity of enteroviruses 19. It also showed effects on hepatic monooxygenase activities in experimental influenza virus infection (EIVI) [124] . Molecular docking studies suggested that rutin can act as a novel hepatitis B virus inhibitor [125] . This flavonoid has also been indicated that hesperidin inhibits cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS) proteins, which might be related to the anti-inflammatory and anti-tumorigenic efficacies [128] . It comes out as a multi-potent phytochemical agent in Alzheimer's disease therapeutics exhibiting strong proteases ßsecretase-1 binding ability (BACE1), high amyloidß peptide (Aß) aggregation inhibition, from a phytochemical library of 200 phytochemicals through the multi-target screening to identify multi-potent [129] . Furthermore, can block coronavirus from entering host cells through ACE2 receptors which can prevent the infection.

Anti-viral activity of hesperidin might constitute a treatment option for COVID-19 through improving host cellular immunity against infection and its good anti-inflammatory activity may help in controlling cytokine storm [130] 

The authors declare that they have no known competing finan-cial interests or personal relationships that could have appeared to influence the work reported in this paper. 

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Table 5 . Virtual toxicity studies of the best ten scoring ligands for both SARS-CoV-2 Mpro and spike glycoprotein

A novel coronavirus from patients with pneumonia in China

WHO coronavirus disease (COVID-19) dashboard. WHO. Accessed 03

COVID-19 Coronavirus pandemic

Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors

Potential therapeutic targets for combating SARS-CoV-2 : drug repurposing, clinical trials and recent advancements

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Structural basis of receptor recognition by SARS-CoV-2

Complementary and alternative medical therapies

Antiepileptic potential of Anisomeles indica (Linn.) Kuntze aerial parts in pentylenetetrazole-induced experimental convulsions in Wistar rats

Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening

Screening of cryptogamic secondary metabolites as putative inhibitors of SARS-CoV-2 main protease and ribosomal binding domain of spike glycoprotein by molecular docking and molecular dynamics approaches

International Journal of Antimicro-bial Agents Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking

Volatile constituents of Saussurea costus roots cultivated in Uttarakhand Himalayas

Determination of flavonoid compounds from Saussurea involucrata by liquid chromatography electrospray ionization mass spectrometry

Saussurea involucrata: A review of the botany, phytochemistry and ethnopharmacology of a rare traditional herbal medicine

In vitro anti-inflammatory effects of cynaropicrin, a sesquiterpene lactone, from Saussurea lappa

Antihepatotoxic activity of Saussurea lappa extract on D-galactosamine and lipopolysaccharide-induced Hepatitis in mice

In vitro anti-Helicobacter pylori action of 30 Chinese herbal medicines used to treat ulcer diseases

The hexane extract of Saussurea lappa and its active principle, dehydrocostus lactone, inhibit prostate cancer cell migration

Evaluation of wound healing properties of Saussurea lappa Clarke root extracts

Acylated flavone glycosides from the roots of Saussurea lappa and their antifungal activity

Pharmacological evaluation of anticonvulsant activity of root extract of Saussurea lappa in mice

Essential oil composition and larvicidal activity of Saussurea lappa roots against the mosquito Aedes albopictus (Diptera: Culicidae)

Isolation of betulinic acid, its methyl ester and guaiane sesquiterpenoids with protein tyrosine phosphatase 1B inhibitory activity from the roots of Saussurea lappa

Saussurea species from the Altai Mountain sandadja centarea, and their flavonoid diversity

The Plant List, Version 1.1

Study on the antiinflammatory and analgesic effects of various purified parts from Saussurea involucrata

Effect of Saussurea involucrata culture on mouse immune function

Quality evaluation of snow lotus (Saussurea): quantitative chemical analysis and antioxidant activity assessment

Antihypoxicactivity at simulated high altitude was isolated in petroleum ether extract of Saussurea involucrata

Tibetan preparatory medicine and preparation method thereof. Chinese Patent CN 1161849A

Chinese medicinal composition for treatment of trachitis and gastritis. Chinese Patent CN 1129134A

The cost of drug development: a systematic review

Search for b2 Adrenergic Receptor Ligands by Virtual Screening via Grid Computing and Investigation of Binding Modes by Docking and Molecular Dynamics Simulations

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Gauss View 5.0.8

Using redundant internal coordinates to optimize equilibrium geometries and transition states

Ab initio calculation of vibrational absorption and circular dichroism spectra using density functional force fields

Alantolides and cyclocostunolides from Saussurea lappa

Topical treatments of Saussurea costus root and Thuja orientalis L. synergistically alleviate atopic dermatitis-like skin lesions by inhibiting proteaseactivated receptor-2 and NF-κB signaling in HaCaT cells and Nc/Nga mice

Antitrypanosomal sesquiterpene lactones from Saussurea costus Fitoterapia

Determination of arctiin in seeds of Saussurea involucrata by HPLC

Terpenoids-XXI, The structure of costunolide, a new sesquiterpene lactone from costus root oil

Study on chemical constituents of Saussurea lappa II

Novelceramidesfrom aerial partsof Saussurea involucrata Kar.et.Kir

Simultaneous determination of five flavonoidsin Saussurea involucrata by capillaryelectrophoresis

Flavonoid diversity of Saussurea and Serratula species in Tien Shan Mountains

Identification and determination of the major constituents in the traditional Uighur medicinal plant Saussurea involucrata by LC-DAD-MS

Chemical constituents from the cell cultures of Saussurea involucrata

Indian medicinal plants. Derhadun: International Book Distributors

A review of therapeutic potential of Saussurea lappa-An endangered plant from Himalaya

Ethnobotany of Kashmir-I. Sind Valley

Generating the Responses Immune with Honey, Saussurea costus, and Nigella Sativa in Cellular and Humoral May Resolve COVID-19?

Active compounds from Saussurea lappa Clarks that suppress hepatitis B virus surface antigen gene expression in human hepatoma cells

Biochemical and computational approach of selected phytocompounds from Tinospora crispa in the management of COVID-19

The Many Roles of Computation in Drug Discovery

Evaluation of docking performance: comparative data on docking algorithms

Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines

Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach

Identification of polyphenols from Broussonetia papyrifera as SARS CoV-2 main protease inhibitors using in silico docking and molecular dynamics simulation approaches

Ur-Rahman, A. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation

Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: a molecular docking and simulation studies

Discovery of potential flavonoid inhibitors against COVID-19 3CL proteinase based on virtual screening strategy

Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds

Revealing the potency of citrus and galangal constituents to halt SARS-CoV-2 infection

Potential Natural Compounds for Preventing SARS-CoV-2 (2019-nCoV) Infection. Preprints

Emerging coronaviruses: genome structure, replication, and pathogenesis

Computational selection of flavonoid compounds as inhibitors against SARS-CoV-2 main protease, RNA-dependent RNA polymerase and spike proteins: A molecular docking study

Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (M) and Spike (S) Glycoprotein Inhibitors: a Molecular Docking Study

Data, disease and diplomacy: GISAID's innovative contribution to global health

GISAID: Global initiative on sharing all influenza data -from vision to reality

Recent advances in SARS-CoV-2 Spike protein and RBD mutations comparison between new variants Alpha (B.1.1.7, United Kingdom), Beta (B.1.351, South Africa), Gamma (P.1, Brazil) and Delta (B.1.617.2, India)

Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra

Potential inhibitors of SARS-CoV-2 (COVID 19) spike protein of the delta and delta plus variant: In silico studies of medicinal plants of North-East India

Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E

The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

The SARS Coronavirus Receptor ACE-2 A Potential Target for Antiviral Therapy

Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: an in silico analysis

Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa

Higher infectivity of the SARS-CoV-2 new variants is associated with K417N/T, E484K, and N501Y mutants: An insight from structural data

Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom

Repurposing therapeutics for covid-19: Supercomputerbased docking to the sars-cov-2 viral spike protein and viral spike protein-human ace2 interface

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor

In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19

Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2

Optimization and Evaluation of propolis liposomes as a promising therapeutic approach for COVID-19

Investigation of potential inhibitor properties of ethanolic propolis extracts against ACE-II receptors for COVID-19 treatment by Molecular Docking Study

Identification of potential natural inhibitors of SARS-CoV2 main protease bymolecular docking and simulation studies

In search of SARS CoV-2 replication inhibitors: Virtual screening,molecular dynamics simulations and ADMET analysis

Screening of cryptogamic secondary metabolites as putative inhibitors of SARS-CoV-2 main protease and ribosomal binding domain of spike glycoprotein by molecular docking and molecular dynamics approaches

Microbial natural products as potential inhibitors of SARS-CoV-2 main protease (Mpro)

A computational investigationon the structure, global parameters and antioxidant capacity of a polyphenol, Gallic acid

Antioxidant properties of selected 4-phenyl hydroxycoumarins: Integrated in vitro and computational studies

Molecular orbital theory of orientation inaromatic, heteroaromatic, and other conjugated molecules

Activation hardness: new index for describing the orientation of electrophilic aromatic substitution

Structural, spectroscopic characterization of 2-(5-methyl-1-benzofuran-3-yl) acetic acid in monomer, dimer and identification of specific reactive, drug likeness properties: Experimental and computational study

Synthesis, crystal and molecular-electronic structure, and kinetic investigation of two new sterically hindered isomeric forms of the dimethyl[methyl(phenylsulfonylamino] benzensulfony chloride

Antiinflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat

Rutin exerts antitumor effects on nude mice bearing SW480 tumor

Rutin exerts antiulcer effect by inhibiting the gastric proton pump

Effect of rutin and chloroquine on white leghorn chickens infected with Plasmodium (Bennettinia) juxtanucleare. Trop Anim Health Prod

Antimicrobial and antiinflammatory activity of the hydrogels containing rutin delivery

Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents

Rutin attenuates gentamicin-induced renal damage by reducing oxidative stress, inflammation, apoptosis, and autophagy in rats

Protective effect of rutin on paracetamoland CCl4-induced hepatotoxicity in rodents

Effects of rutin and quercetin on monooxygenase activities in experimental influenza virus infection

Plant-derived antiviral drugs as novel hepatitis B virus inhibitors: cell culture and molecular docking study

Molecular docking analysis of rutin reveals possible inhibition of SARS-CoV-2 vital proteins

dual character of flavonoids in influenza A virus replication and spread through modulating cellautonomous immunity by MAPK signaling pathways

Inhibition of inducible isoforms of cyclooxygenase and nitric oxide synthase by flavonoid hesperidin in mouse macrophage cell line

Multi-target screening mines hesperidin as a multi-potent inhibitor: Implication in Alzheimer's disease therapeutics

Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection

The authors convey their hearty thanks to the Algerian Ministry of High Education for providing facilities to carry out the research work.

 Table 6 . Tangshenoside III, Rutin and Hesperidin geometrical parameters calculated in a.u at the B3LYP/6-31G(d,p) level of theory.